Tao Li
58Patents
12h-index
93Co-inventors
87Inventor score
Filing activity: Mar 10, 1997 → Nov 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7056714B2 | Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use | Chemistry; Metallurgy | 28 | Expired |
| US7160876B2 | Fused bicycloheterocycle substituted quinuclidine derivatives | Chemistry; Metallurgy | 28 | Expired |
| US7425433B2 | Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use | Chemistry; Metallurgy | 28 | Expired |
| US7902222B2 | Biaryl substituted azabicyclic alkane derivatives | Chemistry; Metallurgy | 24 | Active |
| US7872017B2 | Fused bicycloheterocycle substituted azabicyclic alkane derivatives | Chemistry; Metallurgy | 22 | Active |
| US7674794B2 | Fused bicycloheterocycle substituted quinuclidine derivatives | Chemistry; Metallurgy | 22 | Active |
| US7399765B2 | Substituted diazabicycloalkane derivatives | Human Necessities | 19 | Expired |
| US8314119B2 | Azaadamantane derivatives and methods of use | Chemistry; Metallurgy | 17 | Active |
| US5795759A | Carboxylic acid reductase, and methods of using same | Chemistry; Metallurgy | 16 | Expired |
| US7482141B2 | Methods and compositions for vitamin K epoxide reductase | Chemistry; Metallurgy | 12 | Active |
| US7309699B2 | 3-Quinuclidinyl amino-substituted biaryl derivatives | Human Necessities | 12 | Expired |
| US8853241B2 | Biaryl substituted azabicyclic alkane derivatives | Chemistry; Metallurgy | 12 | Active |
| US9845457B2 | Maintenance of genomic stability in cultured stem cells | Chemistry; Metallurgy | 11 | Active |
| US9249392B2 | Methods and compositions for maintaining genomic stability in cultured stem cells | Chemistry; Metallurgy | 11 | Active |
| US7645602B2 | Methods and compositions for producing vitamin K dependent proteins | Chemistry; Metallurgy | 10 | Active |
| US9790527B2 | Engineered proline hydroxylase polypeptides | Emerging Cross-Sectional Technologies | 9 | Active |
| US7687233B2 | Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage | Chemistry; Metallurgy | 8 | Expired |
| US10370688B2 | Methods for hydroxylyation of chemical compounds | Emerging Cross-Sectional Technologies | 7 | Active |
| US7858318B2 | Methods and compositions for vitamin K epoxide reductase | Chemistry; Metallurgy | 7 | Active |
| US7524665B2 | Methods and compositions for vitamin K epoxide reductase | Chemistry; Metallurgy | 7 | Active |
| US6261814A | Carboxylic acid reductase, and methods of using same | Chemistry; Metallurgy | 5 | Expired |
| US8163916B2 | Azaadamantane ester and carbamate derivatives and methods of use thereof | Human Necessities | 5 | Active |
| US8987453B2 | Azaadamantane derivatives and methods of use | Chemistry; Metallurgy | 4 | Active |
| US8097410B2 | Methods and compositions for vitamin K epoxide reductase | Chemistry; Metallurgy | 4 | Active |
| US8648074B2 | Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers | Human Necessities | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.